List of companies in AbbVie Ventures's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Caribou Biosciences is a Berkeley, California—based private biopharmaceutical company founded in 2011 by Jennifer Doudna and Rachel Haurwitz. | ||||||
Rheostat, located at 300 Technology Square, in Cambridge, Massachusetts is a biotech company developing treatments for neurodegenerative diseases by targeting mitophagy and autophagy pathways. | ||||||
Exicure is a Chicago, Illinois-based biotechnology company that was founded in 2011. | ||||||
Artios Pharma develops cancer treatments that target DNA damage response (DDR) pathways to kill cancer cells selectively | ||||||
Alector is a San Francisco, California biotechnology company developing treatments for neurodegeneration and cancer through immuno-neurology and immuno-oncology. | ||||||
Rodeo Therapeutics is a preclinical-stage biotech company focused on first in class small molecule modulators of prostaglandin biology for enhancing tissue repair and regeneration. | ||||||
A company dedicated on the discovery and development of small molecule therapeutics to treat cancer | ||||||
Palleon Pharmaceuticals is a glycoimmune Checkpoint Inhibitors founded in 2016. | ||||||
Nitrase Therapeutics is a Brisbane, California-based company offering a biopharmaceutical platform, Nitrome, designed to offer therapies against a broad variety of diseases. | ||||||
Accent Therapeutics is a RNA-modifying protein inhibitors founded in 2017 by Robert Copeland. | ||||||
Developer of surfaceome-targeted therapies for hard-to-treat tumors | ||||||
Stemson Therapeutics is an iPSC Hair Loss Treatment founded by Geoff Hamilton. | ||||||
Enthera is an IGFBP3 Inhibitors - Monoclonal Antibody, Fusion Proteins founded in 2016. | ||||||
ApoGen Biotechnologies is a cancer drugs founded by John Santini, Reuben Harris and Daniel Harki. | ||||||
Quanta Therapeutics, Inc. is a company founded in 2018. | ||||||
ALS targeting drugs | ||||||
